Clinical trial

Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

NCT01105429

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-05-01

PhasePHASE1

Study timeline

Study start (unknown)2010-05-01Date precision: month

Registry last updated2011-03-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Non-Insulin-Dependentunresolved

Interventions

BMS-820132DRUG

PlaceboDRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

MiamiFlorida, United States2 Chula VistaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01105429 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.